Table 2 Details of dogs in field study investigating the efficacy of ProHeart® 12 against Dirofilaria immitis
Category | Treatment groupa | ||
|---|---|---|---|
T01 | T02 | Total | |
Heartgard® Plus | ProHeart® 12 | ||
No. of females (spayed/intact) | 152 (143/9) | 163 (149/14) | 315 (53.0%) |
No. of males (neutered/intact) | 145 (120/25) | 134 (107/27) | 279 (47.0%) |
Initial age in years (range) | 4.7 (1.0–13.0) | 4.9 (0.8–14.0) | 4.8 (0.8–14) |
Recent/recurring disease, n (%) | 55 (18.5) | 46 (15.5) | 101 (17.0) |
Receiving therapeutics/prophylactics for recurrent disease, n (%) | 107 (36.0) | 104 (35.0) | 211 (35.5) |
Pure-bred/mixed breed (%) | 52.9/47.1 | 54.9/45.1 | 53.9/46.1 |
Time spent, n (%) | |||
Indoors and outdoors | 106 (35.7) | 113 (38.0) | 219 (36.9) |
Mostly indoors | 176 (59.3) | 170 (57.2) | 346 (58.2) |
Mostly outdoors | 15 (5.1) | 14 (4.7) | 29 (4.9) |